High-Flux Hemodialysis Has Advantages
High-flux hemodialysis confers a definite survival advantage in high-risk patients compared with low-flux hemodialysis, according to results from a long-term, prospective trial presented here for the first time.
Print Issue: October 01, 2007
Taking Aim at Acute Kidney Injury
Acute kidney injury (AKI) is a complex disorder for which there is no uniform definition. AKI has been reported in up to 7% of hospitalized patients, but epidemiologic studies are sparse and confounded by differences in case definitions and heterogeneity in patient populations.
High-Dose ARBs May Benefit Diabetics
High doses of valsartan reduce albuminuria to a greater extent than the conventional 160 mg dose in type 2 diabetics, researchers concluded.
Novel Peptide-Based ESA Promising
BARCELONA—A novel peptide-based erythropoiesis-stimulating agent (ESA) called Hematide safely raises hemoglobin levels in anemic CKD patients and maintains stable hemoglobin levels in hemodialysis patients who switch to the drug from epoetin alfa, data suggest.
RLS and Mortality Linked
Restless leg syndrome (RLS) is an independent predictor of mortality in kidney transplant patients, a study found.
A Closer Look at Home Hemodialysis
As patients, physicians, dialysis providers, and payers search for more favorable outcomes in patients with end-stage renal disease (ESRD), alternative dialysis regimens have gained popularity. Among these therapies are dialysis treatments that are performed more frequently, for longer periods of time, and/or at the patient’s home.
Hemodialysis May Improve Cognition
Removal of uremic toxins by hemodialysis improves cognitive function, data suggest.
NSF: A New Concern for ESRD Patients
Nephrogenic systemic fibrosis (NSF) is a new fibrotic skin disease entity that was first recognized in 1997 in 15 patients re-ceiving hemodialysis.
Gadolinium Peril Confirmed
Scottish researchers have confirmed an association between gadolinium-based contrast agent use and development of nephrogenic systemic fibrosis (NSF) in patients with renal failure undergoing renal replacement therapy (RRT), according to a report in Radiology (2007; published online ahead of print).
Stronger Warnings on Type 2 Diabetes Drugs’ Labels
Manufacturers of certain drugs approved to treat type 2 diabetes have agreed to add an upgraded “boxed” warning emphasizing that the drugs may cause or worsen heart failure in certain patients.
- Loading...
Loading...
Loading... 
Loading...